Introduction of Subcutaneous Depot Medroxyprogesterone Acetate (DMPA-SC) Injectable Contraception at Facility and Community Levels: Pilot Results From 4 Districts of Uganda

Odwe, George; Gray, Kate; Kyarimpa, Annet; Obare, Francis; Nagendi, Grace

doi:10.9745/ghsp-d-18-00117

Cited by 11 publications

(17 citation statements)

References 16 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…All studies were published between 2006 and 2020. In 20 studies, the number of healthcare providers that received training in LARC ( n = 4942) was reported, 17‐37 whereas eight studies did not report the number of providers that received training 20,38‐44 . A total of 6 112 544 women and 5331 healthcare facilities were included in the different studies.…”

Section: Resultsmentioning

confidence: 99%

“…It is important to note that there were several confounding factors present in the interventions of the 27 cohort studies. In 18 studies 17‐19,22,24,25,28‐31,33,34,36,40,42‐44 a steady supply of contraceptives was ensured simultaneously with the training intervention, which may have influenced the positive changes in uptake. Likewise, 12 studies 17,24,32‐36,38,40,42‐44 arranged activities to improve community awareness of the availability of LARCs, as well as to dispel myths and end‐user misconceptions surrounding LARCs.…”

Section: Resultsmentioning

confidence: 99%

“…17,18,[20][21][22][23][24]27,29,32,35,37,[39][40][41][42]44 Our primary outcome of interest, end-use of LARC, was reported in all 28 included studies, and was measured as (1) change in uptake of LARC -including number of women choosing LARC to be their first method of contraception as well as women switching to LARC from a different method [18][19][20]24,25,[27][28][29][30][31][32][35][36][37][38][39][40][41][42][43][44] ; and (2) change in IUD uptake specifically -including postpartum intrauterine devices. 17,[21][22][23]26,33,34 No studies reported the number of unintended pregnancies at 12 months after initiating LARC use, and 15 studies reported the preferred LARC method among healthcare workers and women. 19,…”

Section: Re Sultsmentioning

confidence: 99%

“…17,[21][22][23]26,33,34 No studies reported the number of unintended pregnancies at 12 months after initiating LARC use, and 15 studies reported the preferred LARC method among healthcare workers and women. 19,20,25,[27][28][29][30][31][32]36,38,[40][41][42][43] Uptake of other contraceptives was measured in 19 studies, including use of SARC methods, 19,24,27,28,31,32,37,[39][40][41] overall users of family planning methods 18,25,30,[32][33][34][36][37][38]40,41,43,44 and users of oral contraceptives specifically. 27,28,30,31,…”

Section: Re Sultsmentioning

confidence: 99%

See 3 more Smart Citations

Training of healthcare providers and use of long‐acting reversible contraception in low‐ and middle‐income countries: A systematic review

Baekgaard

Damhaugh

Mrema

et al. 2021

Acta Obstet Gynecol Scand

View full text Add to dashboard Cite

Introduction Unintended pregnancy, a major global health issue resulting in unsafe terminations of pregnancy and maternal deaths in low‐ and middle‐income countries, could be significantly reduced through increased use of modern contraception, including long‐acting reversible contraceptives (LARC). Training of healthcare providers to administer such contraceptives may improve uptake. We conducted a systematic review to collate the end‐user uptake data following training of healthcare providers in low‐ and middle‐income countries. Material and methods We searched PubMed, Embase, the Global Health Library and the Cochrane Library up to 23 May 2020. The review was restricted to low‐ and middle‐income countries and focused on healthcare providers who had received training in LARC. Studies that reported contraceptive uptake among women, preference of LARC among healthcare workers and/or women, and unplanned pregnancies within 12 months of LARC initiation were included. All included studies underwent quality assessment using either the Cochrane Risk of Bias Tool or the Newcastle‐Ottawa Scale. PROSPERO registration number CRD42020185291. Results A total of 28 studies (end‐users n = 6 112 544) were included (27 cohort studies and one randomized trial). Nineteen studies were set in Africa, five in Asia, one in Central America and four were multi‐country studies. Twenty‐eight studies reported LARC use among women, and 25 studies found an increase in uptake of LARC by women using short‐acting methods switching to longer‐acting methods or by recruiting new users of LARC. The randomized controlled trial was assessed as high quality and reported positive findings; however, there was great heterogeneity in the type of intervention and of how outcomes were measured among the other included studies. Further, the quality of these studies varied, although it should be noted that the poor‐quality studies reflected the trends of those of higher quality. Conclusions Despite heterogeneity, current evidence indicates that training of healthcare providers in LARC may increase the uptake among women in low‐ and middle‐income countries. More robust studies are warranted to inform policy.

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

Section: Re Sultsmentioning

confidence: 99%

Section: Re Sultsmentioning

confidence: 99%

See 2 more Smart Citations

Training of healthcare providers and use of long‐acting reversible contraception in low‐ and middle‐income countries: A systematic review

Baekgaard

Damhaugh

Mrema

et al. 2021

Acta Obstet Gynecol Scand

View full text Add to dashboard Cite

show abstract

“…The assumption (and sometimes reality) of poor-quality data is a common academic explanation for not attempting secondary analysis of NGO data [8]. However, it is not true of all NGO data [148]; for example, the NGO, Reproductive Health Uganda, provides training on data collection, storage and reporting to ensure minimum data standards across their network of 17 health clinics [69]. Entering into collaborations with NGOs working in the field of interest can benefit both partners in their shared aim of improving health outcomes [11,17,167].…”

Section: Opportunities For Ngo Data Usementioning

confidence: 99%

Repurposing NGO data for better research outcomes: a scoping review of the use and secondary analysis of NGO data in health policy and systems research

Masefield

Megaw

Barlow

et al. 2020

Health Res Policy Sys

View full text Add to dashboard Cite

Background: Non-governmental organisations (NGOs) collect and generate vast amounts of potentially rich data, most of which are not used for research purposes. Secondary analysis of NGO data (their use and analysis in a study for which they were not originally collected) presents an important but largely unrealised opportunity to provide new research insights in critical areas, including the evaluation of health policy and programmes. Methods: A scoping review of the published literature was performed to identify the extent to which secondary analysis of NGO data has been used in health policy and systems research (HPSR). A tiered analytical approach provided a comprehensive overview and descriptive analyses of the studies that (1) used data produced or collected by or about NGOs; (2) performed secondary analysis of the NGO data (beyond the use of an NGO report as a supporting reference); and (3) analysed NGO-collected clinical data. Results: Of the 156 studies that performed secondary analysis of NGO-produced or collected data, 64% (n = 100) used NGO-produced reports (mostly to a limited extent, as a contextual reference or to critique NGO activities) and 8% (n = 13) analysed NGO-collected clinical data. Of these studies, 55% (n = 86) investigated service delivery research topics and 48% (n = 51) were undertaken in developing countries and 17% (n = 27) in both developing and developed countries. NGOs were authors or co-authors of 26% of the studies. NGO-collected clinical data enabled HPSR within marginalised groups (e.g. migrants, people in conflict-affected areas), albeit with some limitations such as inconsistent and missing data. Conclusion: We found evidence that NGO-collected and produced data are most commonly perceived as a source of supporting evidence for HPSR and not as primary source data. However, these data can facilitate research in under-researched marginalised groups and in contexts that are hard to reach by academics such as conflict-affected areas. NGO-academic collaboration could help address issues of NGO data quality to facilitate their more widespread use in research. The use of NGO data use could enable relevant and timely

show abstract

Trends in subcutaneous depot medroxyprogesterone acetate (DMPA-SC) use in Burkina Faso, the Democratic Republic of Congo and Uganda

et al. 2019

View full text Add to dashboard Cite

Introduction of Subcutaneous Depot Medroxyprogesterone Acetate (DMPA-SC) Injectable Contraception at Facility and Community Levels: Pilot Results From 4 Districts of Uganda

Cited by 11 publications

References 16 publications

Training of healthcare providers and use of long‐acting reversible contraception in low‐ and middle‐income countries: A systematic review

Training of healthcare providers and use of long‐acting reversible contraception in low‐ and middle‐income countries: A systematic review

Repurposing NGO data for better research outcomes: a scoping review of the use and secondary analysis of NGO data in health policy and systems research

Trends in subcutaneous depot medroxyprogesterone acetate (DMPA-SC) use in Burkina Faso, the Democratic Republic of Congo and Uganda

Contact Info

Product

Resources

About